NCT05503277

Brief Summary

Introduction The Laryngeal Tube Suction Disposable LTS-D and the i-gel are a second generation supraglottic airway device SAD, the devices have a drain tube to allow access to the gastrointestinal. The i-gel is a second generation SAD. Does not need an inflatable cuff because the thermoplastic elastomer provides the seal. The study designs to compare the Oropharyngeal leak pressure (OLP) of LTS-D with the i-gel that allow the use of Pressure Control Ventilation. Materials and methods Approval obtained from the institute Ethics Committee, No 0117-22-BNZ. Written parental consent will be obtained Hundred children (50 patients in each device of both sex, weighing 10-35 kg, with an ASA physical status I, scheduled for elective minor surgery Study design Devices are the pediatric LTS-D and the i-gel. The patients will fast for 6 h for solids and 2 h for clear fluids and will be unpremeditated, anesthesia will initiate following a standardized protocol. Both devices will be inserted blindly by expert pediatric anesthesiologists. Leak pressure, will be determined by closing the expiratory valve of the anesthesia breathing system and a fixed gas flow of 3 l min-1. The airway pressure at which an equilibrium is reached will be noted (maximum 40 cm H2O). Primary outcome: Leak pressure Secondary outcome: SGAD insertion time Fiberoptic view Maneuvers Complications. Statistical Analysis the primary outcome is the leak pressure. Previous pilot conducted in 15 children, the average standard deviation leak pressure found to be 31 cm H20. In order to obtain a statistically representative sample for a 95% CI with a margin error of 2% and a standard deviation of 2 cm H20, the sample sizes of 50 cases are needed for each device. Continuous data presented as mean±SD. For the categorical variables frequencies and percentages will be calculated. SPSS version 20 for statistical analysis. P-values smaller than 0.05 considered statistically significant. Categorical data will be analyzed with Pearson chi-square test Mann-Whitney U test will be performed to analyze non-normally distributed interval scale data and ordinal categorical data. Normally distributed data will be analyzed by t-tests.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 16, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

August 16, 2022

Status Verified

August 1, 2022

Enrollment Period

1 year

First QC Date

August 14, 2022

Last Update Submit

August 14, 2022

Conditions

Keywords

Supraglottic devicesltsdi-gelpediatricseal pressure

Outcome Measures

Primary Outcomes (1)

  • Seal pressure

    Measuring seal pressure

    60 seconds

Secondary Outcomes (1)

  • Device Insertion

    30 seconds

Study Arms (2)

Superglottic airway device LTSD

ACTIVE COMPARATOR

measuring seal pressure

Device: LTSD

Superglottic airway device i-gel

ACTIVE COMPARATOR

measuring seal pressure

Device: i-gel

Interventions

LTSDDEVICE

measuring seal pressure

Superglottic airway device LTSD
i-gelDEVICE

measuring seal pressure

Superglottic airway device i-gel

Eligibility Criteria

Age2 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • ASA I
  • ELECTIVE SURGRY

You may not qualify if:

  • ASA II OR MORE
  • At risk for aspiration
  • Upper respiratory tract symptoms within former 10 days
  • Congenital anatomical malformation
  • A possible difficult airway by history or physical examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Mostafa Somri, DR MD

    Bnai Zion Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Luis Gaitini, Dr MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: observational
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Clinical Professor of Anesthesiology

Study Record Dates

First Submitted

August 14, 2022

First Posted

August 16, 2022

Study Start

November 1, 2022

Primary Completion

November 1, 2023

Study Completion

December 31, 2023

Last Updated

August 16, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share